DCDonn ColbyMD, MPHSlidesetAsia-Pacific HIV Clinical Forum 2019Starting PrEP During Acute HIV Infection: What is the Risk for Antiretroviral Drug Resistance? - Donn ColbyView Slideset
DCDonn ColbyMD, MPHSlidesetAsia-Pacific HIV Clinical Forum 2019Transmitted drug resistance to integrase inhibitors is uncommon in both acute and chronic HIV infection in Bangkok - Donn ColbyView Slideset
KRKiat RuxrungthamMDSlidesetAsia-Pacific HIV Clinical Forum 2019Clinical experience INSTI in Thailand - Kiat Ruxrungtham, MDView Slideset
SOShinichi OkaMD, PhDSlidesetAsia-Pacific HIV Clinical Forum 2019Clinical experience INSTI in Japan S- Shinichi Oka, MD, PhDView Slideset
SlidesetAsia-Pacific HIV Clinical Forum 2019Trends of Genotypic Sensitivity Scores of HIV-1 in Taiwan: Potential Application in the Selection of Single-Tablet Antiretroviral Regimens - Kuan-Yeh LeeView Slideset
SlidesetAsia-Pacific HIV Clinical Forum 2019The Impact of Antiretroviral Drug Resistance in Taiwanese HIV-1-Infected MSM Population Between 2015 and 2018 - Yen-Ju ChenView Slideset
CBCharles BoucherMD, PhDSlidesetAsia-Pacific HIV Clinical Forum 2019Selected INSTI Highlights - CROI 2019 - Charles Boucher, MD, PhDView Slideset
SlidesetViral Hepatitis and Liver DiseaseInternational Viral Hepatitis Elimination Meeting (IVHEM) 2019Oral Prescription Opioid Use should be Considered a Risk Factor for HCV Infection: Another Step Toward HCV Elimination- B. HackView Slideset
SlidesetViral Hepatitis and Liver DiseaseInternational Viral Hepatitis Elimination Meeting (IVHEM) 2019Hepatitis C Elimination in the Netherlands (CELINE): a Nationwide Study Retrieving Lost to Follow-Up Chronic Hepatitis C Patients- M. Van DijkView Slideset
NDNaranjargal DashdorjMD, PhDSlidesetViral Hepatitis and Liver DiseaseInternational Viral Hepatitis Elimination Meeting (IVHEM) 2019Mongolia’s Model for Care- Naranjargal Dashdorj, MD, PhDView Slideset
SlidesetViral Hepatitis and Liver DiseaseInternational Viral Hepatitis Elimination Meeting (IVHEM) 2019Policy Implementation Index Based off of Patient Reported Outcomes: The Hep-CORE Study- A. PalayewView Slideset
SlidesetViral Hepatitis and Liver DiseaseInternational Viral Hepatitis Elimination Meeting (IVHEM) 2019Real-World Challenges to and Opportunities for Microelimination in Two Remote Communities in Northwestern Ontario- D. SmooklerView Slideset
